Itano-gun, Japan

Yasue Konishi

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasue Konishi. Retrieved from https://idiyas.com/inventor/yasue-konishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasue Konishi: Innovator in Cancer Treatment

Introduction

Yasue Konishi is a prominent inventor based in Itano-gun, Japan. She has made significant contributions to the field of oncology through her innovative research and development. Her work focuses on creating effective treatments for various types of cancer.

Latest Patents

Yasue Konishi holds a patent for a method of treating colon, renal, and lung carcinomas. This invention provides an anti-tumor agent and a method for treating tumors wherein gamma-interferon and interleukin-1 are used as active ingredients. This patent showcases her commitment to advancing cancer treatment options.

Career Highlights

Konishi is associated with Otsuka Pharmaceutical Company, Limited, where she continues to work on groundbreaking research. Her dedication to improving patient outcomes through innovative therapies has earned her recognition in the medical community.

Collaborations

She has collaborated with notable colleagues, including Kazuyoshi Kawai and Satoru Nakai, to further enhance her research efforts. These partnerships have contributed to the development of effective cancer treatments.

Conclusion

Yasue Konishi's contributions to cancer treatment through her innovative patent and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to inspire advancements in oncology and improve the lives of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…